“…Recent research has suggested an important role for the reninangiotensin system (RAS), known for its regulation of blood pressure and fluid homeostasis, in both I/R injury and liver regeneration after partial hepatectomy (Takada et al, 2001;Ramalho et al, 2002;Guo et al, 2004). Furthermore, angiotensin-converting enzyme (ACE) inhibitors (captopril and enalapril) and angiotensin II (Ang-II) type 1 receptor blockers (losartan and candesartan) were able to downregulate cellular adhesion molecules (e.g., ICAM-1), inhibit the synthesis of proinflammatory cytokines and chemokines [(e.g., TNFα, cytokine-induced neutrophil chemoattractant-1 (CINC-1)] and reduce I/R injury (Anthuber et al, 1997;Araya et al, 2002;Guo et al, 2004).…”